• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一组西班牙裔患者中探索卡斯特尔曼病:对其组织病理学的认识。

Exploring castleman disease in a cohort of hispanic patients: a recognition to its histopathology.

作者信息

Orozco-Collazo Alfonso, Lizardo-Thiebaud María José, Rodríguez-Rodríguez Sergio, Montante-Montes de Oca Daniel, Riveros-Gilardi Berta, Sánchez-Hernández Beatriz, Seidman-Sorsby Alec, Monroy-Ramos Cinthya, Sandoval-López José Jesús, García-Carrera Isabel, Martínez-Baños Déborah

机构信息

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Instituto Nacional de Pediatria, Mexico City, Mexico.

出版信息

J Hematop. 2025 May 12;18(1):25. doi: 10.1007/s12308-025-00637-7.

DOI:10.1007/s12308-025-00637-7
PMID:40355649
Abstract

Castleman disease is a clinicopathological entity that shares features with hematological, rheumatological, and infectious diseases, making accurate diagnosis essential. The objective of this study is to characterize the clinical and pathological characteristics of CD in a Mexican cohort. A retrospective study was conducted on adult Mexican patients diagnosed with unicentric (UCD) and multicentric (MCD) Castleman disease from 1985 to 2023. Clinical and histopathological characteristics typical of UCD and MCD were observed. POEMS-associated MCD showed a higher relapse rate. The mixed histopathological variant was more prevalent in MCD. Immunohistochemical expression of VEGF-A was elevated in all CD cases. A multidisciplinary diagnostic approach is crucial for accurately categorizing CD. The mixed histopathological variant was more common than previously reported, especially in MCD. Further studies are needed to validate VEGF-A as a biomarker for CD.

摘要

卡斯特曼病是一种临床病理实体,具有血液学、风湿病学和传染病的特征,因此准确诊断至关重要。本研究的目的是描述墨西哥队列中卡斯特曼病的临床和病理特征。对1985年至2023年诊断为单中心(UCD)和多中心(MCD)卡斯特曼病的成年墨西哥患者进行了回顾性研究。观察到UCD和MCD典型的临床和组织病理学特征。与POEMS相关的MCD显示出更高的复发率。混合组织病理学变体在MCD中更为普遍。所有卡斯特曼病病例中VEGF-A的免疫组化表达均升高。多学科诊断方法对于准确分类卡斯特曼病至关重要。混合组织病理学变体比以前报道的更为常见,尤其是在MCD中。需要进一步研究以验证VEGF-A作为卡斯特曼病的生物标志物。

相似文献

1
Exploring castleman disease in a cohort of hispanic patients: a recognition to its histopathology.在一组西班牙裔患者中探索卡斯特尔曼病:对其组织病理学的认识。
J Hematop. 2025 May 12;18(1):25. doi: 10.1007/s12308-025-00637-7.
2
Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.儿童 Castleman 病的临床特征和治疗结局:中国的一项回顾性队列研究。
Eur J Pediatr. 2023 Dec;182(12):5519-5530. doi: 10.1007/s00431-023-05235-2. Epub 2023 Oct 2.
3
Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.儿科Castleman 病:来自两院区回顾性队列研究的临床表现、治疗和结局相关见解。
Pediatr Blood Cancer. 2019 May;66(5):e27613. doi: 10.1002/pbc.27613. Epub 2019 Jan 24.
4
Comprehensive analysis of 65 patients with Castleman disease in a single center in China.中国单中心 65 例血管滤泡性淋巴结增生症患者的综合分析。
Sci Rep. 2022 May 24;12(1):8694. doi: 10.1038/s41598-022-12797-y.
5
The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological features.多学科方法在血管滤泡性淋巴结增生症和血管滤泡性淋巴结增生症样淋巴结病诊断中的应用:20 年临床和病理特征回顾性分析。
Br J Haematol. 2024 Feb;204(2):534-547. doi: 10.1111/bjh.19171. Epub 2023 Nov 12.
6
The French paediatric cohort of Castleman disease: a retrospective report of 23 patients.法国小儿血管滤泡性淋巴结增生症队列研究:23 例患儿的回顾性报告。
Orphanet J Rare Dis. 2020 Apr 17;15(1):95. doi: 10.1186/s13023-020-1345-5.
7
Castleman Disease: A Multicenter Case Series from Turkey.血管滤泡性淋巴结增生症:来自土耳其的多中心病例系列。
Turk J Haematol. 2022 Jun 1;39(2):130-135. doi: 10.4274/tjh.galenos.2022.2021.0670. Epub 2022 Feb 18.
8
Unicentric Castleman Disease: Updates and Novel Insights Into Spindle Cell Proliferations and Aggressive Forms of a Localized Disease.单中心Castleman病:关于梭形细胞增殖及局部侵袭性疾病的最新进展与新见解
Int J Lab Hematol. 2025 Feb;47(1):26-35. doi: 10.1111/ijlh.14395. Epub 2024 Nov 5.
9
From Castleman disease histopathological features to idiopathic multicentric Castleman disease: a multiparametric approach to exclude potential iMCD histopathological mimickers.从 Castleman 病的组织病理学特征到特发性多中心 Castleman 病:一种排除潜在 iMCD 组织病理学模拟物的多参数方法。
J Clin Pathol. 2024 Apr 18;77(5):318-323. doi: 10.1136/jcp-2022-208696.
10
Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.特发性多中心和单中心 Castleman 病及滤泡树突状细胞肉瘤的下一代测序。
Blood Adv. 2018 Mar 13;2(5):481-491. doi: 10.1182/bloodadvances.2017009654.

本文引用的文献

1
The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological features.多学科方法在血管滤泡性淋巴结增生症和血管滤泡性淋巴结增生症样淋巴结病诊断中的应用:20 年临床和病理特征回顾性分析。
Br J Haematol. 2024 Feb;204(2):534-547. doi: 10.1111/bjh.19171. Epub 2023 Nov 12.
2
Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease.副肿瘤性天疱疮揭示了西方单中心 Castleman 病的独特临床和生物学表型。
Br J Haematol. 2023 Jul;202(2):267-278. doi: 10.1111/bjh.18847. Epub 2023 May 23.
3
Clinical characteristics and outcomes of Castleman disease: a multicenter Consortium study of 428 patients with 15-year follow-up.
Castleman病的临床特征与预后:一项对428例患者进行15年随访的多中心联合研究
Am J Cancer Res. 2022 Sep 15;12(9):4227-4240. eCollection 2022.
4
Efficacy and safety of regimens used for the treatment of multicentric Castleman disease: A systematic review.用于治疗多中心Castleman 病的方案的疗效和安全性:系统评价。
Eur J Haematol. 2022 Oct;109(4):309-320. doi: 10.1111/ejh.13823. Epub 2022 Jul 13.
5
Candidate biomarkers for idiopathic multicentric Castleman disease.特发性多中心 Castleman 病的候选生物标志物。
J Clin Exp Hematop. 2022;62(2):85-90. doi: 10.3960/jslrt.22010.
6
Treatment and Outcome of Castleman Disease: A Retrospective Report of 31 Patients.Castleman病的治疗与转归:31例患者的回顾性报告
Ther Clin Risk Manag. 2022 Apr 26;18:499-509. doi: 10.2147/TCRM.S354130. eCollection 2022.
7
Clinical characteristics and prognosis of patients with Castleman disease in a Chinese hospital: paraneoplastic pemphigus is an independent risk factor.中国一家医院Castleman病患者的临床特征及预后:副肿瘤性天疱疮是独立危险因素。
Am J Transl Res. 2022 Feb 15;14(2):1051-1059. eCollection 2022.
8
Castleman disease and TAFRO syndrome: To improve the diagnostic consciousness is the key.卡斯特曼病和TAFRO综合征:提高诊断意识是关键。
World J Clin Cases. 2022 Feb 16;10(5):1536-1547. doi: 10.12998/wjcc.v10.i5.1536.
9
Germinal Centers.生发中心。
Annu Rev Immunol. 2022 Apr 26;40:413-442. doi: 10.1146/annurev-immunol-120419-022408. Epub 2022 Feb 3.
10
Multicentric Castleman disease and the evolution of the concept.多中心性Castleman病及其概念的演变
Pathologica. 2021 Oct;113(5):339-353. doi: 10.32074/1591-951X-351.